Inventor · disambiguated record
Tianlei Ying
Also filed as: YING TIANLEI
7 granted patents·2 pending applications·3 citations·filing 2013–2024
73Inventor score
Files withSUZHOU FORLONG BIOTECHNOLOGY CO LTD3US HEALTH3THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES THE GOVERNMENT1UNIV HONG KONG SCI & TECH1UNIV HONG KONG SCIENCE & TECH1
Top patents by PatentIndex Score
9 records- 0177US9676857B2Soluble engineered monomeric FcUS HEALTH·Filed 2013·Granted Jun 13, 2017·2 cites·20 claims
- 0270US12037404B2Human monoclonal antibodies against EphA4 and their useUNIV HONG KONG SCIENCE & TECH·Filed 2021·Granted Jul 16, 2024·0 cites·2 claims
- 0369US10472412B2Bispecific multivalent fusion proteinsUS HEALTH·Filed 2015·Granted Nov 12, 2019·1 cites·16 claims
- 0464US2025122287A1Igg1 fc monomer and application thereofSUZHOU FORLONG BIOTECHNOLOGY CO LTD·Filed 2024·Application pending·0 cites
- 0559US10633447B2Soluble engineered monomeric FcTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES THE GOVERNMENT·Filed 2017·Granted Apr 28, 2020·0 cites·12 claims
- 0657US10934360B2Human monoclonal antibodies against EPHA4 and their useUNIV HONG KONG SCI & TECH·Filed 2015·Granted Mar 2, 2021·0 cites·12 claims
- 0754US2024101639A1FC Monomer Polypeptide and Application ThereofSUZHOU FORLONG BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0848US12168689B2IgG1 FC monomer and application thereofSUZHOU FORLONG BIOTECHNOLOGY CO LTD·Filed 2018·Granted Dec 17, 2024·0 cites·13 claims
- 0945US10421802B2Human monoclonal antibodies against the middle east respiratory syndrome coronavirus (MERS-CoV) and engineered bispecific fusions with inhibitory peptidesUS HEALTH·Filed 2014·Granted Sep 24, 2019·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →